Nephrol Dial Transplant 2014;29:2004–2011.
10 Peng ZY, Zhou F, Kellum JA: Cross-species validation of cell cycle arrest markers for acute kidney injury in the rat during sepsis. Intensive Care Med Exp 2016;4:12.
11 Gupta RK, Chhibber S, Harjai K: Quorum sensing signal molecules cause renal tissue inflammation through local cytokine responses in experimental UTI caused by Pseudomonas aeruginosa. Immunobiology 2013;218:181–185.
12 Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al: Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 2013;309:1154–1162.
13 Chen J, Hartono JR, John R, Bennett M, Zhou XJ, Wang Y, et al: Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 2011;80:504–515.
14 Solini A, Usuelli V, Fiorina P: The dark side of extracellular ATP in kidney diseases. J Am Soc Nephrol 2015;26:1007–1016.
15 Gerritsma JS, Hiemstra PS, Gerritsen AF, Prodjosudjadi W, Verweij CL, Van Es LA, et al: Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 1996;103:289–294.
16 Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, et al: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004;32:2173–2182.
17 Husi H, Sanchez-Niño MD, Delles C, Mullen W, Vlahou A, Ortiz A, et al: A combinatorial approach of proteomics and systems biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC Syst Biol 2013;7:110.
18 Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, et al: Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol 2008;295:F1397–F1403.
19 Heng B, Li Y, Shi L, Du X, Lai C, Cheng L, et al: A meta-analysis of the significance of granzyme B and perforin in noninvasive diagnosis of acute rejection after kidney transplantation. Transplantation 2015;99:1477–1486.
20 Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, Portilla D, et al: Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci 2012;893–894:107–113.
21 Cantaluppi V, Medica D, Mannari C, Stiaccini G, Figliolini F, Dellepiane S, et al: Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis. Nephrol Dial Transplant 2015;30:410–422.
22 Zafrani L, Gerotziafas G, Byrnes C, Hu X, Perez J, Lévi C, et al: Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. Am J Respir Crit Care Med 2012;185:744–755.
23 Meziani F, Delabranche X, Asfar P, Toti F: Bench-to-bedside review: circulating microparticles – a new player in sepsis? Crit Care 2010;14:236.
24 Mastronardi ML, Mostefai HA, Meziani F, Martínez MC, Asfar P, Andriantsitohaina R: Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit Care Med 2011;39:1739–1748.
25 Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, et al: Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013;17:R278.
26 Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, et al: The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients. Crit Care 2016;20:196.
27 Lorente L, Martín MM, Varo N, Borreguero-León JM, Solé-Violán J, Blanquer J, et al: Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 2011;15:R97.
28 Rimmelé T, Payen D, Cantaluppi V, Marshall J, Gomez H, Gomez A, et al: Immune cell phenotype and function in sepsis. Shock 2016;45:282–291.
29 Barbar SD, Binquet C, Monchi M, Bruyère R, Quenot JP: Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial. Trials 2014;15:270.
30 Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007;2:431–439.
31 Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, et al: Acute renal failure in patients with severe sepsis and septic shock – a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant 2008;23:904–909.
32 Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D: Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563–1570.
33 Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000;161:1429–1436.
34 Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al: A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014;41:3–11.
35 Ronco C, Kellum JA, Bellomo R, House AA: Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 2008;3:531–544.
36 Oh HJ, Shin DH, Lee MJ, Koo HM, Doh FM, Kim HR, et al: Early initiation
